egfr kinase assay kit (BPS Bioscience)
BPS Bioscience is a verified supplier 
BPS Bioscience manufactures this product 
95
Structured Review
BPS Bioscience
egfr kinase assay kit
Egfr Kinase Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/egfr+kinase+assay+kit/EGFR+Kinase+Assay+Kit/pm42790246-477-8-15
Average 95 stars, based on 127 article reviews
Egfr Kinase Assay Kit, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 95/100, based on 127 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/egfr+kinase+assay+kit/EGFR+Kinase+Assay+Kit/pm42790246-477-8-15
Average 95 stars, based on 127 article reviews
egfr kinase assay kit - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Activity Assay:Article Title: High-throughput screening of EGFR/Ca 2+ signaling modulators in cardiac hypertrophy using a tetrahedral DNA nanostructure-based hESC platform Article Snippet: For drug screening, hESC-CMs were pretreated with natural compounds (10 μM) for 3 h, followed by stimulation with Ang II (10 μM) for 24 h. TDN-EA (10 nM) was added, and fluorescence was measured using a multimode plate reader (PerkinElmer; Boston, MA, USA). .. Cellular EGFR activity was quantified using an Article Title: High-Throughput Screening of EGFR/Ca2+ Signaling Modulators in Cardiac Hypertrophy Using a Tetrahedral DNA Nanostructure-Based hESC Platform Article Snippet: .. Cellular EGFR activity was quantified using an Kinase Assay:Article Title: High-throughput screening of EGFR/Ca 2+ signaling modulators in cardiac hypertrophy using a tetrahedral DNA nanostructure-based hESC platform Article Snippet: For drug screening, hESC-CMs were pretreated with natural compounds (10 μM) for 3 h, followed by stimulation with Ang II (10 μM) for 24 h. TDN-EA (10 nM) was added, and fluorescence was measured using a multimode plate reader (PerkinElmer; Boston, MA, USA). .. Cellular EGFR activity was quantified using an Article Title: Cell membrane electrostatically cloaked dendrimeric nanocarbons for high-bioactivity and -stability natural drug screening. Article Snippet: Methanol (99.8%, HPLC grade, 34860), acetonitrile (99.9%, HPLC grade, 34851), formic acid (98%, HPLC grade, 43804) and alamethicin (≥98%, Sigma-Aldrich, A4665) were purchased from Merck (Darmstadt, Germany). .. Article Title: Synthesis of Imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-Linked 1,2,3-Triazole Hybrids as Potent EGFR-Targeting Anti-Lung Cancer Agents Article Snippet: Objective: This study describes the design, synthesis, and biological evaluation of novel imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazole hybrids acting as potent inhibitors of the epidermal growth factor receptor (EGFR) in lung cancer pathways.. Methods: A series of 1,2,3-triazole derivatives (VIIa–VIIo) was synthesized via a one-pot 1,3-dipolar cycloaddition reaction of 6-(chloromethyl)-3-(1-methyl-1H-imidazol2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine 8,8-dioxide (V) with sodium azide and various aryl alkynes at 60°C.. The in vitro antiproliferative activity of these newly developed hybrids was evaluated against human lung cancer cell lines using the standard MTT cell viability assay. Article Title: Unveiling the bioactive landscape of drug inactive ingredients (DIGs) using deep transfer learning Article Snippet: .. ADP-Glo kinase assay kit (Promega biotech, USA); ATP (Promega biotech, USA); ß-carotene (HY-N0411, 7235-40-7, MedChemExpress, China); bicinchoninic acid assay (BCA) (Beyotime, China); chlorhexidine (T1000, 55-56-1, Targetmol, USA); dodecyl gallate (T20648, 1166-52-5, Targetmol, USA); Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS) (Gibco, USA); Article Title: High-Throughput Screening of EGFR/Ca2+ Signaling Modulators in Cardiac Hypertrophy Using a Tetrahedral DNA Nanostructure-Based hESC Platform Article Snippet: .. Cellular EGFR activity was quantified using an Article Title: Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Antibreast Cancer Agents and Computational Studies Article Snippet: .. The in vitro EGFR tyrosine kinase inhibition of potent compounds was evaluated using Article Title: Design, synthesis, and molecular modeling of quinoline-linked diphenylpyrazoles as multitarget EGFR, VEGFR-2, and COX-2 inhibitors with anticancer, anti-inflammatory and apoptosis-inducing properties. Article Snippet: .. EGFRWT and EGFRT790M kinase activities were evaluated using Article Title: Targeting EGFR With Quinazoline-4-One/Chalcone Hybrids: Design, Synthesis, and Anticancer Evaluation. Article Snippet: A series of novel quinazoline‐4‐one/chalcone hybrids (4a–4j) were synthesized and evaluated as epidermal growth factor receptor (EGFR) inhibitors with anticancer activity.. The target compounds were in vitro tested against MCF‐7 and HepG2 cancer cell lines, and the EGFR enzyme.. Compounds 4a and 4g were the most potent EGFR inhibitors (IC50 = 0.09 μM and 0.10 μM, respectively), compared to the standard erlotinib (IC50 = 0.16 μM). Synthesized:Article Title: Synthesis of Imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-Linked 1,2,3-Triazole Hybrids as Potent EGFR-Targeting Anti-Lung Cancer Agents Article Snippet: Objective: This study describes the design, synthesis, and biological evaluation of novel imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazole hybrids acting as potent inhibitors of the epidermal growth factor receptor (EGFR) in lung cancer pathways.. Methods: A series of 1,2,3-triazole derivatives (VIIa–VIIo) was synthesized via a one-pot 1,3-dipolar cycloaddition reaction of 6-(chloromethyl)-3-(1-methyl-1H-imidazol2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine 8,8-dioxide (V) with sodium azide and various aryl alkynes at 60°C.. The in vitro antiproliferative activity of these newly developed hybrids was evaluated against human lung cancer cell lines using the standard MTT cell viability assay. Article Title: Targeting EGFR With Quinazoline-4-One/Chalcone Hybrids: Design, Synthesis, and Anticancer Evaluation. Article Snippet: A series of novel quinazoline‐4‐one/chalcone hybrids (4a–4j) were synthesized and evaluated as epidermal growth factor receptor (EGFR) inhibitors with anticancer activity.. The target compounds were in vitro tested against MCF‐7 and HepG2 cancer cell lines, and the EGFR enzyme.. Compounds 4a and 4g were the most potent EGFR inhibitors (IC50 = 0.09 μM and 0.10 μM, respectively), compared to the standard erlotinib (IC50 = 0.16 μM). Isolation:Article Title: Synthesis of Imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-Linked 1,2,3-Triazole Hybrids as Potent EGFR-Targeting Anti-Lung Cancer Agents Article Snippet: Objective: This study describes the design, synthesis, and biological evaluation of novel imidazole-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-1,2,3-triazole hybrids acting as potent inhibitors of the epidermal growth factor receptor (EGFR) in lung cancer pathways.. Methods: A series of 1,2,3-triazole derivatives (VIIa–VIIo) was synthesized via a one-pot 1,3-dipolar cycloaddition reaction of 6-(chloromethyl)-3-(1-methyl-1H-imidazol2-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine 8,8-dioxide (V) with sodium azide and various aryl alkynes at 60°C.. The in vitro antiproliferative activity of these newly developed hybrids was evaluated against human lung cancer cell lines using the standard MTT cell viability assay. Acid Assay:Article Title: Unveiling the bioactive landscape of drug inactive ingredients (DIGs) using deep transfer learning Article Snippet: .. ADP-Glo kinase assay kit (Promega biotech, USA); ATP (Promega biotech, USA); ß-carotene (HY-N0411, 7235-40-7, MedChemExpress, China); bicinchoninic acid assay (BCA) (Beyotime, China); chlorhexidine (T1000, 55-56-1, Targetmol, USA); dodecyl gallate (T20648, 1166-52-5, Targetmol, USA); Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS) (Gibco, USA); Modification:Article Title: Unveiling the bioactive landscape of drug inactive ingredients (DIGs) using deep transfer learning Article Snippet: .. ADP-Glo kinase assay kit (Promega biotech, USA); ATP (Promega biotech, USA); ß-carotene (HY-N0411, 7235-40-7, MedChemExpress, China); bicinchoninic acid assay (BCA) (Beyotime, China); chlorhexidine (T1000, 55-56-1, Targetmol, USA); dodecyl gallate (T20648, 1166-52-5, Targetmol, USA); Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS) (Gibco, USA); In Vitro:Article Title: Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Antibreast Cancer Agents and Computational Studies Article Snippet: .. The in vitro EGFR tyrosine kinase inhibition of potent compounds was evaluated using Inhibition:Article Title: Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Antibreast Cancer Agents and Computational Studies Article Snippet: .. The in vitro EGFR tyrosine kinase inhibition of potent compounds was evaluated using Mutagenesis:Article Title: Targeting EGFR With Quinazoline-4-One/Chalcone Hybrids: Design, Synthesis, and Anticancer Evaluation. Article Snippet: A series of novel quinazoline‐4‐one/chalcone hybrids (4a–4j) were synthesized and evaluated as epidermal growth factor receptor (EGFR) inhibitors with anticancer activity.. The target compounds were in vitro tested against MCF‐7 and HepG2 cancer cell lines, and the EGFR enzyme.. Compounds 4a and 4g were the most potent EGFR inhibitors (IC50 = 0.09 μM and 0.10 μM, respectively), compared to the standard erlotinib (IC50 = 0.16 μM). |
